Should Value Investors Buy Johnson Matthey (JMPLY) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the market at large.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One stock to keep an eye on is Johnson Matthey (JMPLY). JMPLY is currently sporting a Zacks Rank #1 (Strong Buy), as well as a Value grade of A. The stock is trading with a P/E ratio of 13.17, which compares to its industry's average of 18.29. Over the past year, JMPLY's Forward P/E has been as high as 13.44 and as low as 6.77, with a median of 8.63.These are only a few of the key metrics included in Johnson Matthey's strong Value grade, but they help show that the stock is likely undervalued right now. When factoring in the strength of its earnings outlook, JMPLY looks like an impressive value stock at the moment.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Johnson Matthey PLC (JMPLY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Quelle: Zacks
Nachrichten zu Johnson Matthey plc
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Johnson Matthey plc
Datum | Rating | Analyst | |
---|---|---|---|
23.10.2012 | Johnson Matthey neutral | UBS AG | |
22.03.2012 | Johnson Matthey buy | UBS AG | |
08.12.2011 | Johnson Matthey kaufen | Focus Money | |
25.11.2011 | Johnson Matthey buy | UBS AG | |
23.11.2011 | Johnson Matthey neutral | Credit Suisse Group |
Datum | Rating | Analyst | |
---|---|---|---|
22.03.2012 | Johnson Matthey buy | UBS AG | |
08.12.2011 | Johnson Matthey kaufen | Focus Money | |
25.11.2011 | Johnson Matthey buy | UBS AG | |
13.10.2011 | Johnson Matthey buy | UniCredit Research | |
21.07.2011 | Johnson Matthey buy | UniCredit Research |
Datum | Rating | Analyst | |
---|---|---|---|
23.10.2012 | Johnson Matthey neutral | UBS AG | |
23.11.2011 | Johnson Matthey neutral | Credit Suisse Group | |
23.11.2011 | Johnson Matthey neutral | Citigroup Corp. | |
11.10.2011 | Johnson Matthey neutral | Citigroup Corp. | |
05.10.2011 | Johnson Matthey hold | Citigroup Corp. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Johnson Matthey plc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen